Literature DB >> 11229608

Biological significance of reducing glucose degradation products in peritoneal dialysis fluids.

A Wieslander1, T Linden, B Musi, O Carlsson, R Deppisch.   

Abstract

UNLABELLED: Carbohydrates are not stable when exposed to energy; they degrade into new molecules. In peritoneal dialysis (PD) fluids, degradation of glucose occurs during the heat sterilization procedure. The biological consequences of this degradation are side effects such as impaired proliferation and impaired host defense mechanisms, demonstrated in vitro for a great variety of cells. Several highly toxic compounds--such as formaldehyde and 3-deoxyglucosone--have been identified in PD fluids. Carbonyl compounds, apart from being cytotoxic, are also well-known promoters of irreversible advanced glycation end-products (AGEs), which might participate in the long-term remodeling of the peritoneal membrane. Various approaches can be used to reduce the formation of glucose degradation products (GDPs) during heat sterilization. Some examples are shortening the sterilization time, lowering the pH, removing catalyzing substances, and increasing glucose concentration. The latter three factors are employed in the multi-compartment bag with a separate chamber containing pure glucose at high concentration and low pH. Gambrosol trio, a PD fluid produced in this way, shows reduced cytotoxicity, normalized host defense reactions, less AGE formation, and reduced concentrations of formaldehyde and 3-deoxyglucosone. Moreover, in the clinical situation, the fluid turns out to be more biocompatible for the patient, causing less mesothelial cell damage, which in the long term could lead to a more intact peritoneal membrane.
CONCLUSION: Glucose degradation products in heat-sterilized fluids for peritoneal dialysis are cytotoxic, promote AGE formation, and cause negative side effects for the patient. Using improved and well-controlled manufacturing processes, it is possible to produce sterile PD fluids with glucose as the osmotic agent but without the negative side effects related to GDPs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11229608

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  4 in total

Review 1.  Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?

Authors:  Murali Krishnan; Paul Tam; George Wu; Andrzej Breborowicz; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study.

Authors:  Masaaki Nakayama; Masanobu Miyazaki; Kazuho Honda; Kenji Kasai; Tadashi Tomo; Hidetomo Nakamoto; Hideki Kawanishi
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

3.  Evolving concepts on the age-related changes in "muscle quality".

Authors:  David W Russ; Kimberly Gregg-Cornell; Matthew J Conaway; Brian C Clark
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-02-03       Impact factor: 12.910

4.  Effect of benfotiamine in podocyte damage induced by peritoneal dialysis fluid.

Authors:  Sandra Müller-Krebs; Katharina Nissle; Julia Tsobaneli; Martin Zeier; Lars Philipp Kihm; Zoltan Kender; Thomas Fleming; Peter Paul Nawroth; Jochen Reiser; Vedat Schwenger
Journal:  Front Med (Lausanne)       Date:  2015-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.